RxDoctor Payments Data

Steven Todd

Radiation Oncology · Pocatello, IDNPI 1972604510

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 145 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 38 manufacturers, the largest accounting for just 11.2% — the pattern of someone who eats at a lot of different presentations.

$2,354in general payments, 2019–2025

Across 145 payments — averaging $16.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$263
  • Novartis$217
  • Daiichi Sankyo Inc.$179
  • Bayer$178
  • Isoray, Inc$173
  • Amgen$118
  • plus $1K from 32 others

What the payments were for

  • Food & beverage$2,354100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,354 in reported general payments places this provider in the 80th percentile of 22 radiation oncology providers in Idaho.

See all radiation oncology providers in Idaho

Other radiation oncology in Pocatello

See the full list for Idaho

Where these figures come from

Is this you, or does something look wrong? →